Keyphrases
MicroRNA
100%
Myocardial Ischemia-reperfusion Injury
100%
Peroxisome Proliferator-activated Receptor Agonists
100%
MiR-29a
100%
MicroRNA-29
100%
Antisense Inhibitor
100%
Pioglitazone
85%
Ischemia-reperfusion Injury
71%
Apoptosis
28%
Peroxisome Proliferator-activated Receptor
28%
H9c2 Cells
28%
Receptor Antagonist
14%
Overexpressing
14%
Attenuation
14%
Cell Apoptosis
14%
Cell Survival
14%
Pharmacological Intervention
14%
Western Blot Analysis
14%
Cell Proliferation
14%
Protective Effect
14%
Receptor Activation
14%
Expression Level
14%
Days of Treatment
14%
Rosiglitazone
14%
Bcl-2 Family
14%
Antagomir
14%
Caspase-3 Activity
14%
Northern Blot
14%
Rat Heart
14%
Myocardial Infarct Size
14%
Simulated Ischemia
14%
Anti-apoptotic Bcl-2
14%
Expression Change
14%
GW9662
14%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Myocardial Ischemia Reperfusion Injury
100%
PPAR Agonist
100%
microRNA 29
100%
Pioglitazone
85%
Reperfusion Injury
71%
Peroxisome Proliferator Activated Receptor
28%
microRNA 29a
28%
Western Blot
14%
Antiapoptotic
14%
Caspase 3
14%
Heart Infarction
14%
Rosiglitazone
14%
Ascorbic Acid
14%
2 Chloro 5 Nitrobenzanilide
14%
Antagomir
14%